After finishing at $233.27 in the prior trading day, Steris Plc (NYSE: STE) closed at $227.09, down -2.65%. In other words, the price has decreased by -$6.18 from its previous closing price. On the day, 524259 shares were traded.
Ratios:
Our goal is to gain a better understanding of STE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 114.72 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 37.78. For the most recent quarter (mrq), Quick Ratio is recorded 1.49 and its Current Ratio is at 2.43. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.53.
On May 30, 2023, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $206.
Piper Sandler Downgraded its Overweight to Neutral on April 14, 2023, whereas the target price for the stock was revised from $215 to $197.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 16 ’23 when Breeden Richard C sold 12,130 shares for $208.61 per share. The transaction valued at 2,530,439 led to the insider holds 27,970 shares of the business.
FELDMANN CYNTHIA L sold 2,058 shares of STE for $430,239 on May 16 ’23. The Director now owns 705 shares after completing the transaction at $209.06 per share. On May 15 ’23, another insider, KOSECOFF JACQUELINE B, who serves as the Director of the company, sold 4,657 shares for $212.56 each. As a result, the insider received 989,892 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STE now has a Market Capitalization of 22.44B and an Enterprise Value of 25.75B. As of this moment, Steris’s Price-to-Earnings (P/E) ratio for their current fiscal year is 39.83, and their Forward P/E ratio for the next fiscal year is 23.83. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.98. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.15 while its Price-to-Book (P/B) ratio in mrq is 3.50. Its current Enterprise Value per Revenue stands at 4.76 whereas that against EBITDA is 18.47.
Stock Price History:
Over the past 52 weeks, STE has reached a high of $254.00, while it has fallen to a 52-week low of $180.54. The 50-Day Moving Average of the stock is 226.64, while the 200-Day Moving Average is calculated to be 220.19.
Shares Statistics:
The stock has traded on average 400.21K shares per day over the past 3-months and 385.46k shares per day over the last 10 days, according to various share statistics. A total of 98.63M shares are outstanding, with a floating share count of 98.52M. Insiders hold about 0.30% of the company’s shares, while institutions hold 96.57% stake in the company. Shares short for STE as of Feb 29, 2024 were 2.46M with a Short Ratio of 6.15, compared to 2.15M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.49% and a Short% of Float of 2.84%.
Dividends & Splits
In the trailing 12 months, STE’s forward annual dividend rate was 1.98, compared to 2.03 this year. Against a Trailing Annual Dividend Yield of 0.85%, it implies a Forward Annual Dividend Yield of 0.92%. The stock’s 5-year Average Dividend Yield is 0.88. The current Payout Ratio is 172.33% for STE, which recently paid a dividend on Mar 22, 2024 with an ex-dividend date of Feb 22, 2024. Stock splits for the company last occurred on Aug 25, 1998 when the company split stock in a 2:1 ratio.
Earnings Estimates
Its stock is currently analyzed by 7 different market analysts. On average, analysts expect EPS of $2.42 for the current quarter, with a high estimate of $2.52 and a low estimate of $2.36, while EPS last year was $2.3. The consensus estimate for the next quarter is $2.21, with high estimates of $2.3 and low estimates of $2.11.
Analysts are recommending an EPS of between $8.7 and $8.62 for the fiscal current year, implying an average EPS of $8.66. EPS for the following year is $9.53, with 7 analysts recommending between $9.65 and $9.39.
Revenue Estimates
6 analysts predict $1.45B in revenue for the current quarter. It ranges from a high estimate of $1.46B to a low estimate of $1.42B. As of the current estimate, Steris Plc’s year-ago sales were $1.38B, an estimated increase of 4.60% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $1.38B, an increase of 14.30% over than the figure of $4.60% in the same quarter last year. There is a high estimate of $1.4B for the next quarter, whereas the lowest estimate is $1.36B.
A total of 7 analysts have provided revenue estimates for STE’s current fiscal year. The highest revenue estimate was $5.5B, while the lowest revenue estimate was $5.43B, resulting in an average revenue estimate of $5.47B. In the same quarter a year ago, actual revenue was $4.96B, up 10.30% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $5.83B in the next fiscal year. The high estimate is $5.87B and the low estimate is $5.77B. The average revenue growth estimate for next year is up 6.70% from the average revenue estimate for this year.
